Grifols Therapeutics Investing $351M In Clayton, NC Expansion

The global healthcare company will create 300 jobs at a new specialized blood plasma facility and logistics center at its Clayton, NC campus.


https://businessfacilities.com/2020/06/grifols-therapeutics-investing-351m-clayton-north-carolina-expansion/
The global healthcare company will create 300 jobs at a new specialized blood plasma facility and logistics center at its Clayton, NC campus.
Facebooktwitterredditpinterestlinkedintumblrmail

Grifols Therapeutics Investing $351M In North Carolina Expansion

The global healthcare company will create 300 jobs at a new specialized blood plasma facility and logistics center at its Clayton, NC campus.

Grifols Therapeutics Investing $351M In Clayton, NC Expansion

Grifols Therapeutics will expand its North Carolina operations with a new $351.6 million capital investment, creating 300 jobs. The Spanish healthcare company will construct a specialized blood plasma facility and logistics center at its Clayton campus in Johnston County, NC.

Grifols Therapeutics, Clayton, NC
(Photo: Grifols Therapeutics)

“Today is a very exciting day for Grifols. We are extremely proud to expand our manufacturing operations in the state of North Carolina,” said Doug Burns, President of Grifols Therapeutics. “True to Grifols mission of improving the health and wellbeing of patients, our new state-of-the-art fractionation facility will help meet the growing demand for plasma-derived medicines in the United States and around the world. We thank Governor Cooper, Secretary of Commerce Anthony Copeland, the Economic Development Partnership of N.C., the North Carolina General Assembly, the North Carolina Community College System, Johnston County, the Town of Clayton, and the Johnston County Economic Development Office for their strong support.”

Grifols Therapeutics is a leading supplier of medicines derived from human plasma. The company will expand its North Carolina operations with a new plasma fractionation facility and logistics center to help meet the growing demand for plasma derived medicines. Fractionation is the process of separating different components in blood plasma, to produce proteins that are essential for patients who face sometimes life-threatening conditions.

The company is also playing a leadership role in the response to COVID-19 by developing a plasma-based antibody treatment for the disease. In partnership with the federal government, Grifols is collecting convalescent plasma from eligible COVID-19 survivors across the country. Grifols’ 13 plasma collection centers in North Carolina are participating in this important effort. Convalescent plasma from donors will be manufactured into a hyper-immune therapy specific to COVID-19 at the company’s manufacturing campus in Clayton.

“Companies like Grifols continue to choose expansion in North Carolina because our workforce can meet their needs of this important facility,” said Governor Roy Cooper. “During this public health crisis, we have seen the value of manufacturing close to home and this expansion means new, life-saving medicines will be manufactured in Clayton.”

“It’s a challenging time in our state and our nation as the coronavirus pandemic impacts our lives, but today’s decision confirms the fundamentals of the North Carolina economy remain strong,” said Commerce Secretary Anthony M. Copeland. “I welcome Grifols’ vote of confidence to expand their business in our state.”

Grifols Therapeutics’ project in North Carolina will be facilitated, in part, by a Job Development Investment Grant (JDIG) approved by the state’s Economic Investment Committee. Over the course of 12 years, the project is estimated to grow the state’s economy by $1.72 billion. Using a formula that takes into account the new tax revenues generated by the new jobs, the agreement authorizes the potential reimbursement to the company of up to $5,161,500, spread over 12 years. Payments for all JDIGs only occur following performance verification by the departments of Commerce and Revenue that the company has met its incremental job creation and investment targets. JDIG projects result in positive net tax revenue to the state treasury, even after taking into consideration the grant’s reimbursement payments to a given company.

Because Grifols chose a site in Johnston County, classified by the state’s economic tier system as Tier 3, the company’s JDIG agreement also calls for moving as much as $1,721,000 into the state’s Industrial Development Fund – Utility Account. The Utility Account helps rural communities finance necessary infrastructure upgrades to attract future business.

In addition to the North Carolina Department of Commerce and the Economic Development Partnership of N.C., other key partners on this project were the North Carolina General Assembly, the North Carolina Community College System, the North Carolina Biotechnology Center, Johnston County, the Town of Clayton, and Johnston County’s Economic Development Office.

Want to learn more about North Carolina corporate expansion?

Considering North Carolina for your company’s relocation or expansion project? Check out all the latest news related to North Carolina economic development, corporate relocation, corporate expansion and site selection.

Suggested Links:

LEAVE A REPLY